medical_xpress
@zpcbeqyqyryncom
An anti-amyloid drug may halve Alzheimer's dementia risk in genetically predisposed individuals, suggesting early amyloid plaque removal could delay symptom onset. Further research is ongoing. @wustl @TheLancet https://t.co/sNkMskjDld
0 reply
0 recast
0 reaction